EGFR exon 19 deletion + EGFR K754E
|
NSCLC
|
EGFR exon 19 deletion + EGFR K754E
|
NSCLC
|
dacomitinib Resistant: C3 – Early Trials
|
dacomitinib Resistant: C3 – Early Trials
|
EGFR exon 19 deletion + EGFR K754E
|
LUAD
|
EGFR exon 19 deletion + EGFR K754E
|
LUAD
|
afatinib Sensitive: C4 – Case Studies
|
afatinib Sensitive: C4 – Case Studies
|